Caldwell Trust’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100
Closed -$7.78K 754
2021
Q4
$7.78K Hold
100
﹤0.01% 650
2021
Q3
$9.54K Hold
100
﹤0.01% 639
2021
Q2
$12.4K Hold
100
﹤0.01% 627
2021
Q1
$13.2K Hold
100
﹤0.01% 606
2020
Q4
$13.2K Hold
100
﹤0.01% 596
2020
Q3
$10.2K Hold
100
﹤0.01% 608
2020
Q2
$8.69K Hold
100
﹤0.01% 651
2020
Q1
$5.8K Buy
+100
New +$8.12K ﹤0.01% 687

Other funds holding EXAS

Caldwell Trust's EXAS Position: Q1 2022 in Review

Caldwell Trust sold out of Exact Sciences (EXAS) in Q1 2022, closing a stake of 100 shares — an estimated $7.78K sold.

Caldwell Trust first reported a position in EXAS in Q1 2020 and held it in 8 quarters. The position peaked at $13.2K in Q4 2020. 559 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.

  • Caldwell Trust reported no remaining Exact Sciences position as of Q1 2022 after selling out during the quarter.
  • Caldwell Trust sold 100 Exact Sciences shares in Q1 2022, an estimated $7.78K.
  • Caldwell Trust first reported a position in Exact Sciences in Q1 2020 and held it in 8 quarters.
  • Caldwell Trust's Exact Sciences position peaked at $13.2K in Q4 2020.
  • 559 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.

Based on Caldwell Trust's 13F filing for Q1 2022, filed 2 Oct 2025.